Abstract:The human gut is home to trillions of microorganisms that influence several aspects of our health. This dense microbial community targets almost all dietary polysaccharides and releases multiple metabolites, some of which have physiological effects on the host. A healthy equilibrium between members of the gut microbiota, its microbial diversity, and their metabolites is required for intestinal health, promoting regulatory or anti-inflammatory immune responses. In contrast, the loss of this equilibrium due to antibiotics, low fiber intake, or other conditions results in alterations in gut microbiota composition, a term known as gut dysbiosis. This dysbiosis can be characterized by a reduction in health-associated microorganisms, such as butyrate-producing bacteria, enrichment of a small number of opportunistic pathogens, or a reduction in microbial diversity. Bifidobacterium species are key species in the gut microbiome, serving as primary degraders and contributing to a balanced gut environment in various ways. Colonization resistance is a fundamental property of gut microbiota for the prevention and control of infections. This community competes strongly with foreign microorganisms, such as gastrointestinal pathogens, antibiotic-resistant bacteria, or even probiotics. Resistance to colonization is based on microbial interactions such as metabolic cross-feeding, competition for nutrients, or antimicrobial-based inhibition. These interactions are mediated by metabolites and metabolic pathways, representing the inner workings of the gut microbiota, and play a protective role through colonization resistance. This review presents a rationale for how microbial interactions provide resistance to colonization and gut dysbiosis, highlighting the protective role of Bifidobacterium species.

Response, resistance, and recovery of gut bacteria to human-targeted drug exposure

Emergence of community behaviors in the gut microbiota upon drug treatment

Nutrient Competition Predicts Gut Microbiome Restructuring under Drug Perturbations

The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria

Human Gut Microbiota and Drug Metabolism

Drug and gut microbe relationships: Moving beyond antibiotics

Pharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

Interplays between drugs and the gut microbiome

Antibiotic Resistance and Microbiota Response

Extensive impact of non-antibiotic drugs on human gut bacteria

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota

Integrating the gut microbiome and pharmacology

Interaction between drugs and the gut microbiome

High-throughput transcriptomics of 409 bacteria–drug pairs reveals drivers of gut microbiota perturbation

Antibiotic perturbations to the gut microbiome

Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches

The metabolic effect of gut microbiota on drugs

Microbial interactions and the homeostasis of the gut microbiome: the role of Bifidobacterium

Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study

The protective role of commensal gut microbes and their metabolites against bacterial pathogens